Immunological and functional comparison between Clostridium perfringens iota toxin, C. spiroforme toxin, and anthrax toxins.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 8997715)

Published in FEMS Microbiol Lett on January 01, 1997

Authors

S Perelle1, S Scalzo, S Kochi, M Mock, M R Popoff

Author Affiliations

1: Unité des Toxines Microbiennes, CNRS URA1858, Institut Pasteur, Paris, France.

Articles citing this

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev (2004) 2.60

Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc Natl Acad Sci U S A (2002) 2.51

Cellular uptake of the Clostridium perfringens binary iota-toxin. Infect Immun (2001) 1.26

Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. Infect Immun (2011) 1.05

Clostridium perfringens iota toxin: binding studies and characterization of cell surface receptor by fluorescence-activated cytometry. Infect Immun (2000) 1.04

Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib. Infect Immun (2001) 1.02

Detergent-resistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens iota-toxin. Infect Immun (2004) 0.93

Clostridium and bacillus binary enterotoxins: bad for the bowels, and eukaryotic being. Toxins (Basel) (2014) 0.91

The long-lived nature of clostridium perfringens iota toxin in mammalian cells induces delayed apoptosis. Infect Immun (2009) 0.86

Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen. Gut Microbes (2014) 0.86

Clostridial binary toxins: iota and C2 family portraits. Front Cell Infect Microbiol (2011) 0.86

CD44 Promotes intoxication by the clostridial iota-family toxins. PLoS One (2012) 0.85

A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins. Infect Immun (1997) 0.85

Bacteria within the Gastrointestinal Tract Microbiota Correlated with Improved Growth and Feed Conversion: Challenges Presented for the Identification of Performance Enhancing Probiotic Bacteria. Front Microbiol (2016) 0.84

Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.80

Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer. Mol Cancer (2014) 0.78

Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT. Toxins (Basel) (2014) 0.78

Identification and Characterization of a New Enterotoxin Produced by Clostridium perfringens Isolated from Food Poisoning Outbreaks. PLoS One (2015) 0.78

Articles by these authors

(truncated to the top 100)

Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87

Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun (1998) 4.44

The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J (1989) 4.21

Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun (1991) 4.17

Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J (2000) 3.83

Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol (1999) 3.49

Clostridium perfringens: toxinotype and genotype. Trends Microbiol (1999) 3.21

Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol (1988) 3.11

Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett (1999) 3.00

Construction and characterization of a protective antigen-deficient Bacillus anthracis strain. Mol Microbiol (1990) 2.67

Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation. EMBO J (2000) 2.66

Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997. J Clin Microbiol (1998) 2.51

Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun (1997) 2.42

Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA. FEMS Microbiol Lett (1996) 2.34

Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol (2001) 2.30

The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence. Mol Microbiol (1995) 2.22

The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol Microbiol (2001) 2.20

Polymerase chain reaction assay for diagnosis of potentially toxinogenic Corynebacterium diphtheriae strains: correlation with ADP-ribosylation activity assay. J Clin Microbiol (1993) 2.14

Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol Microbiol (1999) 2.12

A technique for integrating any DNA fragment into the chromosome of Escherichia coli. Gene (1984) 2.11

Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem (1994) 2.09

Characterization of the Bacillus anthracis S-layer: cloning and sequencing of the structural gene. J Bacteriol (1995) 2.01

The wall peptidoglycans of Neisseria perflava, Moraxella glucidolytica, Pseudomonas alcaligenes and Proteus vulgaris strain P18. Eur J Biochem (1973) 1.99

Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli. Infect Immun (1993) 1.99

Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell-associated antigen. Mol Microbiol (1997) 1.96

Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene (1997) 1.93

Role of toxin functional domains in anthrax pathogenesis. Infect Immun (2000) 1.93

Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell (1992) 1.86

The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature. J Bacteriol (1994) 1.85

Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun (1995) 1.81

Nucleotide sequence of Clostridium botulinum C1 neurotoxin. Nucleic Acids Res (1990) 1.74

Toxins of Bacillus anthracis. Toxicon (2001) 1.74

Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun (1987) 1.72

Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70

Sequences of the botulinal neurotoxin E derived from Clostridium botulinum type E (strain Beluga) and Clostridium butyricum (strains ATCC 43181 and ATCC 43755). Biochem Biophys Res Commun (1992) 1.62

Structural homology between virulence-associated bacterial adenylate cyclases. Gene (1988) 1.62

The Ba813 chromosomal DNA sequence effectively traces the whole Bacillus anthracis community. J Appl Microbiol (1999) 1.49

Construction of Bacillus anthracis mutant strains producing a single toxin component. J Gen Microbiol (1993) 1.43

Mechanism of colicin E3 production in strains harboring wild-type or mutant plasmids. J Bacteriol (1978) 1.39

ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction. Cardiovasc Drugs Ther (2001) 1.38

Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS) Int J Cardiol (1989) 1.37

AtxA activates the transcription of genes harbored by both Bacillus anthracis virulence plasmids. FEMS Microbiol Lett (1997) 1.37

Molecular tools for the study of transcriptional regulation in Bacillus anthracis. Res Microbiol (1996) 1.32

The BtuB group col plasmids and homology between the colicins they encode. J Bacteriol (1982) 1.31

A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly. EMBO J (1993) 1.31

The capsule and S-layer: two independent and yet compatible macromolecular structures in Bacillus anthracis. J Bacteriol (1998) 1.30

Evidence that Arg-295, Glu-378, and Glu-380 are active-site residues of the ADP-ribosyltransferase activity of iota toxin. FEBS Lett (1996) 1.28

Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. Int J Med Microbiol (2000) 1.27

The small GTP-binding protein Rho1p is localized on the Golgi apparatus and post-Golgi vesicles in Saccharomyces cerevisiae. J Cell Biol (1991) 1.26

Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D. Nucleic Acids Res (1990) 1.26

Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett (2000) 1.26

Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol (1997) 1.26

botR/A is a positive regulator of botulinum neurotoxin and associated non-toxin protein genes in Clostridium botulinum A. Mol Microbiol (1998) 1.25

Differential influence of the two Bacillus anthracis plasmids on regulation of virulence gene expression. Infect Immun (1996) 1.24

The vacuolar ATPase proton pump is required for the cytotoxicity of Bacillus anthracis lethal toxin. FEBS Lett (1996) 1.24

TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect Immun (1998) 1.20

Detection of the beta2 toxin gene of Clostridium perfringens in diarrhoeic piglets in The Netherlands and Switzerland. FEMS Immunol Med Microbiol (1999) 1.20

Organization of the botulinum neurotoxin C1 gene and its associated non-toxic protein genes in Clostridium botulinum C 468. Mol Gen Genet (1994) 1.19

Regulation of pag gene expression in Bacillus anthracis: use of a pag-lacZ transcriptional fusion. FEMS Microbiol Lett (1992) 1.17

Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem (2001) 1.15

Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Infect Immun (1999) 1.14

Clostridium orbiscindens sp. nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring. Int J Syst Bacteriol (1991) 1.13

Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans. Nature (1974) 1.12

Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin. Infect Immun (1995) 1.11

PCR and gene probe identification of botulinum neurotoxin A-, B-, E-, F-, and G-producing Clostridium spp. and evaluation in food samples. Appl Environ Microbiol (1995) 1.11

Polymerase chain reaction for the rapid identification of Clostridium botulinum type A strains and detection in food samples. J Appl Bacteriol (1993) 1.10

Bacillus anthracis pXO1 virulence plasmid encodes a type 1 DNA topoisomerase. Mol Microbiol (1994) 1.10

A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon (1991) 1.10

Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response. Eur J Immunol (1974) 1.09

Bacterial toxins modifying the actin cytoskeleton. Int Microbiol (1999) 1.07

Molecular biology of S-layers. FEMS Microbiol Rev (1997) 1.06

Clostridium perfringens urease genes are plasmid borne. Infect Immun (1997) 1.06

Inferring maps of forces inside cell membrane microdomains. Phys Rev Lett (2009) 1.05

The S-layer homology domain as a means for anchoring heterologous proteins on the cell surface of Bacillus anthracis. J Appl Microbiol (1999) 1.05

Identification of Clostridium butyricum and Clostridium beijerinckii by gas-liquid chromatography and sugar fermentation: correlation with DNA homologies and electrophoretic patterns. J Gen Microbiol (1983) 1.04

Clostridium perfringens iota toxin: binding studies and characterization of cell surface receptor by fluorescence-activated cytometry. Infect Immun (2000) 1.04

Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell Microbiol (2000) 1.04

Clostridium perfringens iota-toxin requires activation of both binding and enzymatic components for cytopathic activity. Infect Immun (2000) 1.03

Zinc content of the Bacillus anthracis lethal factor. FEMS Microbiol Lett (1994) 1.03

Distribution of S-layers on the surface of Bacillus cereus strains: phylogenetic origin and ecological pressure. Environ Microbiol (2001) 1.03

Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib. Infect Immun (2001) 1.02

Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin. Infect Immun (1999) 1.01

The cell envelope in Proteus vulgaris P 18. Isolation and characterization of the peptidoglycan component. Biochim Biophys Acta (1971) 1.01

Mutations which affect the structure and activity of colicin E3. J Bacteriol (1980) 1.00

[Adjuvant activity of Gram-negative bacterial peptidoglycans in delayed hypersensitivity]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.98

Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase. Biochemistry (1990) 0.98

Bacillus anthracis surface: capsule and S-layer. J Appl Microbiol (1999) 0.98

Macrophage interactions. Curr Top Microbiol Immunol (2002) 0.97

Taxonomic position of lecithinase-negative strains of Clostridium sordellii. J Gen Microbiol (1985) 0.97

Genome structure and evolution of the Bacillus cereus group. Curr Top Microbiol Immunol (2002) 0.97

Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346. Biochemistry (1991) 0.96

Detection of enterotoxigenic Clostridium perfringens in food and fecal samples with a duplex PCR and the slide latex agglutination test. Appl Environ Microbiol (1997) 0.96

Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function by chloroquine and related compounds in vitro and intoxification in vivo. FASEB J (2001) 0.95

Characterization of a plasmid region involved in Bacillus anthracis toxin production and pathogenesis. Int J Med Microbiol (2000) 0.95

Plasmid localization of a type E botulinal neurotoxin gene homologue in toxigenic Clostridium butyricum strains, and absence of this gene in non-toxigenic C. butyricum strains. FEMS Microbiol Lett (1992) 0.95

Experimental cecitis in gnotoxenic chickens monoassociated with Clostridium butyricum strains isolated from patients with neonatal necrotizing enterocolitis. Infect Immun (1985) 0.95

Nucleotide sequence for the catalytic domain of colicin E3 and its immunity protein. Evidence for a third gene overlapping colicin. Nucleic Acids Res (1983) 0.95

Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol (2007) 0.94

[Adjuvant activity of monomeric fractions of bacterial peptidoglycans in delayed hypersensitivity]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.94

[Penicillin-induced filamentous forms in Proteus vulgaris P 18 ]. Ann Inst Pasteur (Paris) (1972) 0.92